SCHEMBL6560079

SCHEMBL6560079

Nc1ccc(C(=O)N2CCCC(=O)C2)cc1

nearest known ligand 0.50

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
HPGD P15428 7/20 0.50
ALDH1A1 P00352 4/20 0.50
CA12 O43570 3/20 0.49
CA1 P00915 3/20 0.49
CA2 P00918 3/20 0.49
CA7 P43166 3/20 0.49
CA9 Q16790 3/20 0.49
CA14 Q9ULX7 3/20 0.49
KDM4E B2RXH2 1/20 0.45
MEN1 O00255 1/20 0.44
LMNA P02545 1/20 0.44
KMT2A Q03164 1/20 0.44
SMN1; SMN2 Q16637 1/20 0.44
MTHFD2 P13995 3/20 0.44
AVPR2 P30518 1/20 0.43
AVPR1A P37288 1/20 0.43
MGLL Q99685 1/20 0.43
MAPK1 P28482 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6558877 0.90 CA1 (0.51) HPGDALDH1A1CA12CA1CA2
SCHEMBL12460085 0.87 HPGD (0.55) HPGDALDH1A1CA12CA1CA2
SCHEMBL7685753 0.84 ALDH1A1 (0.55) HPGDALDH1A1CA12CA1CA2
SCHEMBL8538640 0.83 HPGD (0.62) HPGDALDH1A1LMNAMTHFD2MAPK1
SCHEMBL4764024 0.81 HPGD (0.69) HPGDALDH1A1CA12CA1CA2
SCHEMBL264516 0.81 HPGD (0.76) HPGDALDH1A1CA12CA1CA2
SCHEMBL8314360 0.80 CA12 (0.58) HPGDALDH1A1CA12CA1CA2
SCHEMBL1590985 0.79 HPGD (0.80) HPGDALDH1A1CA12CA1CA2
SCHEMBL12156421 0.79 HPGD (0.80) HPGDALDH1A1CA12CA1CA2
Hydrochloric Acid SCHEMBL3562269 0.79 HPGD (0.73) HPGDALDH1A1CA12CA1CA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1436255-A1 NOVEL COMPOUNDS AND COMPOSITIONS AS CATHEPSIN INHIBITORS Aventis Pharmaceuticals, Inc. (US) 2004-07-14 EP claimed
WO-2003024924-A1 NOVEL COMPOUNDS AND COMPOSITIONS AS CATHEPSIN INHIBITORS AVENTIS PHARMACEUTICALS INC. (US) 2003-03-27 WO claimed